Use of an EP4 receptor antagonist in the treatment of allergic contact dermatitis and psoriasis

摘要

A compound for use in a method of treating allergic contact dermatitis or psoriasis in an animal subject, including a mammalian subject, wherein the compound is 3- [2- (4- {2-ethyl-4,6- dimethyl-1Himidazo [4,5-c] pyridin-1-yl} phenyl) ethyl] -1 - [(4-methylbenzene) sulfonyl] urea or a pharmaceutically acceptable salt thereof